Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William Proudman"'
Publikováno v:
BMJ Neurology Open, Vol 6, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/4db3d68af62044e188472f53c35ff7dd
Autor:
Kirsty Sharplin, William Proudman, Rakchha Chhetri, Elizabeth Ngoc Hoa Tran, Jamie Choong, Monika Kutyna, Philip Selby, Aidan Sapio, Oisin Friel, Shreyas Khanna, Deepak Singhal, Michelle Damin, David Ross, David Yeung, Daniel Thomas, Chung H. Kok, Devendra Hiwase
Publikováno v:
Cancers, Vol 15, Iss 16, p 4019 (2023)
Azacitidine is an approved therapy for higher-risk myelodysplastic syndrome (MDS). However, only 30–40% patients respond to azacitidine, and the responses may take up to six cycles to become evident. Delayed responses and the myelosuppressive effec
Externí odkaz:
https://doaj.org/article/3b013407b31945fabf523bfeffe0a8cb
Autor:
William Proudman, Oliver Kleinig, Lydia Lam, Luke Collins, Michelle Bagster, Aashray Gupta, Joshua Kovoor, Stephen Bacchi, Mark Slee, WengOnn Chan
Publikováno v:
Seminars in Ophthalmology. :1-7
Autor:
Rakchha Chhetri, Siddarth Nayar, Michelle Damin, Mithun Vinod Shah, Daniel Thomas, Peter Bardy, Devendra K Hiwase, William Proudman, David M. Ross, Akash Kalro, Kirsty Sharplin, Deepak Singhal, Monika M Kutyna
Publikováno v:
Blood. 138:3702-3702
Introduction: Therapy related myeloid neoplasm (t-MN) is a rare but devastating complication of cytotoxic therapy used for management of unrelated malignancy or autoimmune diseases. Therapeutic options for t-MN are limited and although hypomethylatin